EP Patent

EP0481420A1 — Magnetic resonance imaging agent

Assigned to Nihon Medi Physics Co Ltd · Expires 1992-04-22 · 34y expired

What this patent protects

A gadolinium complex of 1,4,7,10-tetraazacyclododecane-1,4,7,10-α,α',α'',α'''-tetrakis(methylacetic acid) or its salt, which is useful as a nuclear magnetic resonance imaging agent.

USPTO Abstract

A gadolinium complex of 1,4,7,10-tetraazacyclododecane-1,4,7,10-α,α',α'',α'''-tetrakis(methylacetic acid) or its salt, which is useful as a nuclear magnetic resonance imaging agent.

Drugs covered by this patent

Patent Metadata

Patent number
EP0481420A1
Jurisdiction
EP
Classification
—
Expires
1992-04-22
Drug substance claim
No
Drug product claim
No
Assignee
Nihon Medi Physics Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.